Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characterization of the Genomic Risk Underlying Retroperitoneal Liposarcoma

NCT06436846 is registered in ClinicalTrials.gov with Fox Chase Cancer Center as lead sponsor.

NCT NCT06436846
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06436846 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characterization of the Genomic Risk Underlying Retroperitoneal Liposarcoma
Lead sponsor
Fox Chase Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
March 7, 2022
Completion date
August 1, 2027
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retroperitoneal liposarcoma, soft tissue sarcoma